CD4 and neoplasm: Moreover, tBregs can also directly activate the regulatory functions of MDSCs-derived monocytes and granulocyte subsets, while activated MDSCs have been shown to improve production of ROS and NO, and more effectively inhibit CD4+ T and CD8+ T cells, thereby promoting tumor metastasis (48).